Search Results - "Lackner, M."

Refine Results
  1. 1

    Development of a free vortex wake method code for offshore floating wind turbines by Sebastian, T., Lackner, M.A.

    Published in Renewable energy (01-10-2012)
    “…Offshore floating wind turbines (OFWTs) present unique aerodynamic analysis challenges. Motion–derived velocity perturbations in the wake necessitate…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Minimal-Contact Versus Standard Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Cost-Effectiveness Results of a Multisite Trial by Dunlap, Laura J, Jaccard, James, Lackner, Jeffrey M

    Published in Annals of behavioral medicine (04-10-2021)
    “…Abstract Background Irritable bowel syndrome (IBS) is a common, often disabling gastrointestinal (GI) disorder for which there is no satisfactory medical…”
    Get full text
    Journal Article
  7. 7

    Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes by Jacobs, Jonathan P, Lagishetty, Venu, Hauer, Megan C, Labus, Jennifer S, Dong, Tien S, Toma, Ryan, Vuyisich, Momchilo, Naliboff, Bruce D, Lackner, Jeffrey M, Gupta, Arpana, Tillisch, Kirsten, Mayer, Emeran A

    Published in Microbiome (10-01-2023)
    “…Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is thought to involve alterations in the gut microbiome, but robust microbial…”
    Get full text
    Journal Article
  8. 8

    Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients by Aigner, M, Wanner, M, Kreidl, P, Lass-Flörl, C, Lackner, M

    Published in Antimicrobial agents and chemotherapy (01-06-2019)
    “…BAL fluid samples from critically ill patients shared a rate of 29% false-positive galactomannan results. We aimed to determine whether species abundance in…”
    Get full text
    Journal Article
  9. 9

    N‐chlorotaurine, a potent weapon against multiresistant bacteria by Anich, C., Orth‐Höller, D., Lackner, M., Nagl, M.

    Published in Journal of applied microbiology (01-10-2021)
    “…Aims N‐chlorotaurine (NCT) is a body‐own mild oxidizing antiseptic that can be applied topically as a well‐tolerated anti‐infective at many body sites. The…”
    Get full text
    Journal Article
  10. 10

    Recent trends in molecular diagnostics of yeast infections: from PCR to NGS by Opathy, Consortium, Gabaldon, Toni

    Published in FEMS microbiology reviews (01-09-2019)
    “…The incidence of opportunistic yeast infections in humans has been increasing over recent years. These infections are difficult to treat and diagnose, in part…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter by Qu, X, Sandmann, T, Frierson, H, Fu, L, Fuentes, E, Walter, K, Okrah, K, Rumpel, C, Moskaluk, C, Lu, S, Wang, Y, Bourgon, R, Penuel, E, Pirzkall, A, Amler, L, Lackner, M R, Tabernero, J, Hampton, G M, Kabbarah, O

    Published in Oncogene (15-12-2016)
    “…Key molecular drivers that underlie transformation of colonic epithelium into colorectal adenocarcinoma (CRC) are well described. However, the mechanisms…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? by Bassetti, M., Vena, A., Bouza, E., Peghin, M., Muñoz, P., Righi, E., Pea, F., Lackner, M., Lass-Flörl, C.

    Published in Clinical microbiology and infection (01-08-2020)
    “…Invasive fungal infections (IFIs) represent a global issue and affect various patient populations. In recent years, resistant fungal isolates showing increased…”
    Get full text
    Journal Article
  17. 17

    Susceptibility and diversity in the therapy-refractory genus scedosporium by Lackner, M, Hagen, F, Meis, J F, Gerrits van den Ende, A H G, Vu, D, Robert, V, Fritz, J, Moussa, T A A, de Hoog, G S

    Published in Antimicrobial agents and chemotherapy (01-10-2014)
    “…Scedosporium species show decreased susceptibility to the majority of systemic antifungal drugs. Acquired resistance is likely to disseminate differentially…”
    Get full text
    Journal Article
  18. 18

    A role for FOXO1 in BCR–ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia by Wagle, M, Eiring, A M, Wongchenko, M, Lu, S, Guan, Y, Wang, Y, Lackner, M, Amler, L, Hampton, G, Deininger, M W, O'Hare, T, Yan, Y

    Published in Leukemia (01-07-2016)
    “…Chronic myeloid leukemia (CML) patients who relapse on imatinib due to acquired ABL1 kinase domain mutations are successfully treated with second-generation…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trial by Thakur, E. R., Holmes, H. J., Lockhart, N. A., Carty, J. N., Ziadni, M. S., Doherty, H. K., Lackner, J. M., Schubiner, H., Lumley, M. A.

    Published in Neurogastroenterology and motility (01-12-2017)
    “…Background Current clinical guidelines identify several psychological treatments for irritable bowel syndrome (IBS). IBS patients, however, have elevated…”
    Get full text
    Journal Article